
$48 Billion — Our most important show ever
Dumb Money Live
00:00
Is Novo Overvalued Right Now?
I don't think it's too expensive right now. I'm just wondering What like it's already got a growth multiple on it. And so you know, what is the outside from here? And that'swhat I've got a that's what I've got to value it. Yes. So if you have a class of drugs that really is going to be $50 billion plus and you have two companies Splitting that up so you have companies that are generating you know 20 plus billion dollars a piece In five years Right from this drug class and let's say it surprises. It's a game changer for 200 billion dollar company at the game changer. But my biggest concern as an
Transcript
Play full episode